LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 23.95 | 21.74 | 5 | 1354 | 0.0037 | -0.2185 | MN20160310_N01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 23.95 | 21.74 | 1323 | 1354 | 0.9767 | 0.9921 | MN20160310_N01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 23.95 | 21.74 | 715 | 1354 | 0.5278 | 0.7967 | MN20160310_N01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 23.95 | 21.74 | 1449 | 1354 | 1.0697 | 1.0227 | MN20160310_N01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 25.92 | 21.74 | 10 | 1515 | 0.0066 | -0.1191 | MN20160310_N01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 25.92 | 21.74 | 1431 | 1515 | 0.9442 | 0.9813 | MN20160310_N01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 25.92 | 21.74 | 908 | 1515 | 0.5991 | 0.8395 | MN20160310_N01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 25.92 | 21.74 | 1560 | 1515 | 1.0293 | 1.0094 | MN20160310_N01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 27.89 | 21.74 | 14 | 1677 | 0.0083 | -0.0678 | MN20160310_N01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 27.89 | 21.74 | 1540 | 1677 | 0.9183 | 0.9730 | MN20160310_N01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 27.89 | 21.74 | 1058 | 1677 | 0.6309 | 0.8583 | MN20160310_N01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 27.89 | 21.74 | 1678 | 1677 | 1.0006 | 1.0002 | MN20160310_N01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 29.86 | 21.74 | 30 | 1887 | 0.0159 | 0.0513 | MN20160310_N01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 29.86 | 21.74 | 1674 | 1887 | 0.8871 | 0.9632 | MN20160310_N01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 29.86 | 21.74 | 1246 | 1887 | 0.6603 | 0.8752 | MN20160310_N01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 29.86 | 21.74 | 1794 | 1887 | 0.9507 | 0.9844 | MN20160310_N01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 31.83 | 21.74 | 45 | 2110 | 0.0213 | 0.1165 | MN20160310_N01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 31.83 | 21.74 | 1879 | 2110 | 0.8905 | 0.9652 | MN20160310_N01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 31.83 | 21.74 | 1324 | 2110 | 0.6275 | 0.8637 | MN20160310_N01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 31.83 | 21.74 | 1958 | 2110 | 0.9280 | 0.9775 | MN20160310_N01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 33.80 | 21.74 | 75 | 2381 | 0.0315 | 0.2005 | MN20160310_N01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 33.80 | 21.74 | 2046 | 2381 | 0.8591 | 0.9557 | MN20160310_N01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 33.80 | 21.74 | 1479 | 2381 | 0.6210 | 0.8642 | MN20160310_N01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 33.80 | 21.74 | 2179 | 2381 | 0.9150 | 0.9739 | MN20160310_N01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 35.77 | 21.74 | 92 | 2602 | 0.0353 | 0.2324 | MN20160310_N01 | D14 |